BBOT·107924102·US·equity·Healthcare - Biotechnology-Activist
BBOT (BRIDGEBIO ONCOLOGY THERAPEUT) is held by 36 institutional investors as of Q1 2026. Largest holders: Alphabet Inc. ($25.3M), WELLINGTON MANAGEMENT GROUP LLP ($25.2M), CITADEL ADVISORS LLC ($22.6M). Net institutional sentiment: Bullish.
See how BBOT's score breaks down across 4 SEC sources
Showing 1-20 of 38
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer